Archives mensuelles: mars2021

Perfusfind S.L.

Abstract Background Miscommunication during clinical handover can lead to partial information transfer and healthcare provider dissatisfaction. We hypothesised that a quality improvement project to standardise the cardiovascular intensive care unit (CVICU)..

Perfusfind S.L.

Abstract Objectives The aim was to evaluate changes in the coagulation profile of cyanotic neonates, to analyze the effects of cardiopulmonary bypass (CPB) with crystalloid priming on their coagulation status,..

Perfusfind S.L.

Abstract Objective Biochemical and cytological pericardial fluid (PF) analysis is essentially based on the knowledge of pleural fluid composition. The aim of the present study is to identify reference intervals (RIs)..

Perfusfind S.L.

Abstract The use of extracorporeal life support (ECLS) is increasingly reported in adult liver transplantation (LT). However, neither the role of ECLS in the perioperative setting for LT nor its..

Perfusfind S.L.

Abstract Introduction: Modified ultrafiltration (MUF) is employed at the termination of cardiopulmonary bypass (CPB) in pediatric and neonatal patients undergoing congenital heart surgery to reduce the accumulation of total body..

Perfusfind S.L.

EOS ECMO is part of the LivaNova ECMO oxygenators family. Equipped with the well known Polymethylpentene Hollow Fiber, it guarantees optimal performance for Pediatric and Adult patients undergoing long duration..

Perfusfind S.L.

Goal-Directed Perfusion and the CONNECT GDPMonitor LivaNova, alongside leading clinicians who have studied the clinical benefits and improved patient outcomes associated with the application of Goal-Directed Perfusion (GDP), is at..

Perfusfind S.L.

The S5 Hybrid version is built on the S5 legacy and its proven reliability. This new addition to the LivaNova portfolio enables perfusionists to perform extracorporeal circulation with flexibility. With..

Perfusfind S.L.

Inspire is a complete family of adult oxygenators designed from years of research and laboratory experience, input from clinical experts from around the world and the application of advanced manufacturing..

Perfusfind S.L.

With more than 7,000 devices delivered and 5,5 million patients treated, perfusionists worldwide are benefiting from the reliability of the S5 heart-lung machine.• Proven safety and reliability • State of..

Perfusfind S.L.

MINIMALLY INVASIVE PERFUSIONINSPIRE® Min.I. is an innovative Minimally Invasive perfusion system bringing safety to the system level.INSPIRE® Min.I. allows a low hemodilution cardiopulmonary bypass (CPB).INSPIRE® Min.I. allows clinicians the choice..

Perfusfind S.L.

Small, sensitive neonatal and pediatric patients deserve dedicated perfusion systems.The Dideco KIDS line of pediatric oxygenators and arterial filters are the latest from a long history of pediatric perfusion advancements..

Perfusfind S.L.

Lilliput 2 ECMO is the new version completing the Lilliput oxygenators' family. Equipped with a long-term usage validated polymethylpentene membrane, it guarantees optimal performance for neonatal and infant patients undergoing..

Perfusfind S.L.

The Connect workflow system minimizes transcription errors, bias and all the drawbacks associated with manual operations.Connect allows trending and electronic transfer of data from LivaNova disposables. The perfusionist accesses all..

Perfusfind S.L.

TABLE OF CONTENTSArterial CannulaeVenous Return CannulaeCardioplegia ProductsVentsSuction ProductsThoracic CathetersBeating Heart ProductsAccessoriesMinimally Invasive Cardiac Surgery Cannulae[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/LN_Adult-Cannulae-Catalogue_IM-02685_compressed.pdf" title="LN_Adult Cannulae Catalogue_IM-02685_compressed"]  

Perfusfind S.L.

LivaNova HEARTLINK is the first perfusion system automatically integrating perfusion data, critical patient parameters and product information to assist with implementation of Goal-Directed Perfusion, improved patient outcomes and increased clinical..

Perfusfind S.L.

TABLE OF CONTENTSArterial CannulaeVenous Return CannulaeCardioplegia CannulaeSuction ProductsVents[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/LN_Pediatric_Cannulae_09295-146-D_compressed.pdf" title="LN_Pediatric_Cannulae_09295-146 D_compressed"]  

Perfusfind S.L.

S5 Min, isn’t just another configuration of the S5 system. Optimized with the aim of improving outcomes during extracorporeal circulation in minimally invasive and pediatric surgery, S5 Min.I. is a..

Perfusfind S.L.

Flexible enough to cover the demands of the most comprehensive MCS program.[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/MCS-Protek-Cannulae-Brochure_compressed.pdf" title="MCS Protek Cannulae Brochure_compressed"]   The ProtekDuo cannula offers a unique RA-PA cannulation strategy. It allows for..

Perfusfind S.L.

Dedicated solutions for all of the different myocardial protection methods.A wide collection of crystalloid, cold and warm blood cardioplegia systems available for delivering your myocardial protection.[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/Myocardial-CPL-solutions_09294-82B_compressed.pdf" title="Myocardial CPL solutions_09294-82B_compressed"]..

Perfusfind S.L.

Reliability, Partnership and Commitment. The Right Combination for your Perfusion Practice.[pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/09/PTS-2017_09295-16C_compressed.pdf" title="PTS 2017_09295-16C_compressed"]  

Perfusfind S.L.

Although arterial filtration is widely recognised as being essential during cardiopulmonary bypass, and is strongly supported by a great deal of scientific literature, there is still considerable debate regarding the..

Perfusfind S.L.

Patient with Fungal and Bacterial endocarditis of RA with extension to IVC first of all beating off pump IVC vegetation excision done then converted to On pump beating in order..

Perfusfind S.L.

Patient with previous thoracoabdominal aneurysm undergone stent graft and came again with acute type A dissection due to stent graft hook out bulging undergone ascending aorta replacement and innominate artery..

Perfusfind S.L.

Abstract The 4th Universal Definition of Myocardial Infarction has stimulated considerable debate since its publication in 2018. The intention was to define the types of myocardial injury through the lens..

Perfusfind S.L.

Abstract An 11-year-old boy with autism and focal idiopathic epilepsy presented to the emergency department at an outside hospital after sudden onset of recurrent vomiting. He was nonverbal at baseline and..

Perfusfind S.L.

Abstract Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed in adulthood. Although considered a simple defect, challenges in optimal diagnostic and treatment options still exist due..

Perfusfind S.L.

Abstract Radiation therapy is an important component of cancer therapy for many malignancies. With improvements in cardiac-sparing techniques, radiation-induced cardiac dysfunction has decreased but remains a continued concern. In this..

Perfusfind S.L.

Abstract Background Elevated plasma free hemoglobin is associated with multi-organ injury. In this context, minimally invasive extracorporeal technologies represent a way to reduce this complication following cardiac surgery. Methods We..

Perfusfind S.L.

Abstract Objectives The authors aimed to assess whether untreated preoperative anemia was associated with increased risk for adverse outcomes after the arterial switch operation in neonates with dextro-transposition of the..